ABSTRACT
OBJECTIVE: Infection of large vessel prostheses is a rare but critical complication. The aim of this work is to assess the impact of PET/CT with 18F-Fluordesoxyglucose (PET-FDG) on the diagnosis of infection in our environment. MATERIAL AND METHODS: Thirty-five patients (38 scans) were evaluated for suspected prosthetic infection. A qualitative analysis was performed taking into account the distribution of the radiopharmaceutical, categorizing the studies as positive or negative for infection. Those with focal or multifocal deposits along the vascular prosthesis were considered positive, and negative if a homogeneous and diffuse distribution over the whole prosthesis was observed, or a total absence of uptake. A semi-quantitative analysis was performed using SUVmax and average SUV values, and a metabolic index was calculated (SUVmax of the graft / average SUV of the normal vascular pool). RESULTS: The PET-FDG study was positive in 20 patients, with a diagnostic accuracy of 84%. The 38 PET-FDG scans performed showed positive capture patterns (focal in 6, multifocal in 15, diffuse in 4) and negative pattern in the remaining 13. The sensitivity, specificity, positive and negative predictive values obtained for the PET-FDG were 95%, 89%, 90% and 94%, and for the AngioTC study 50%, 73%, 73% and 50%, respectively. The area values under the ROC curve were as follows: for the AngioTC 0.642 (not significant), and for the SUVmax values of 0.925 (p<0.005), average SUV of 0.922 (p<0.005) and for the metabolic index of 0.917 (p<0.005). CONCLUSIONS: The PET-FDG proves to be a tool with high diagnostic accuracy in the infection of vascular prosthesis, both visual analysis according to patterns and semi-quantitative.
ABSTRACT
No disponible
Subject(s)
Humans , Female , Aged , Implant Capsular Contracture/diagnostic imaging , Neoplasm Recurrence, Local/diagnostic imaging , Breast Neoplasms/diagnostic imaging , Diagnosis, Differential , Single Photon Emission Computed Tomography Computed Tomography/methods , Fluorodeoxyglucose F18Subject(s)
Breast Implants/adverse effects , Breast Neoplasms/diagnostic imaging , Fluorodeoxyglucose F18 , Neoplasm Recurrence, Local/diagnostic imaging , Positron Emission Tomography Computed Tomography , Prosthesis Failure , Radiopharmaceuticals , Aged , Breast Neoplasms/surgery , Diagnosis, Differential , Female , HumansABSTRACT
OBJECTIVE: To evaluate the efficacy of densitometric analysis of cranial CT imaging in the measurement of areas with low cerebral blood flow and lack of hemodynamic reserve in patients undergoing carotid endarterectomy. PATIENTS AND METHODS: 40 consecutive patients undergoing carotid endarterectomy have been included in the study. All of them had preoperative cranial CT, pre and postoperative basal and acetazolamide SPECT. Cranial CT imaging after digitalization and computer processing were obtained with 4 densitometric patterns: 1). normal cerebral blood perfusion; 2). ischemic or low brain blood perfusion (patron I); 3). parenchyma without cerebral hemodynamic reserve (patron nR), and 4). brain infarction. RESULTS: 32 out of 40 (80 %) patients had abnormal densitometric patterns: 19 nR patterns (47.5 %), 11 I pattern (27.5 %) and 2 established brain infarction. The correlation between densitometric cranial TC imaging and SPECT was 92% when analyzing areas with hypoperfusion (S: 96.5 %; E: 82 %). Cranial CT detected 12/13 of patients who lacked cerebral hemodynamic reserve in the SPECT analysis (S: 74 %; E: 92 %; Vpp: 95 %). CONCLUSIONS: There is a good correlation between analysis of densitometric cranial TC imaging and SPECT in determining low cerebral blood flow areas and lack of cerebral hemodynamic reserve. This method could help to improve carotid surgery indications in patients with carotid stenosis.
Subject(s)
Brain , Endarterectomy, Carotid/methods , Tomography, X-Ray Computed , Aged , Brain/blood supply , Brain/diagnostic imaging , Brain/metabolism , Carotid Stenosis/physiopathology , Carotid Stenosis/surgery , Female , Hemodynamics/physiology , Humans , Male , Middle Aged , Tomography, Emission-Computed, Single-PhotonABSTRACT
Objetivo: Analizar el valor pronóstico de los niveles séricos preoperatorios del antígeno carcinoembrionario (CEA) en el cáncer colorrectal primario. Material y métodos: Se analizaron los niveles séricos preoperatorios del CEA en 275 pacientes con carcinoma colorrectal, que fueron sometidos a un período mínimo de seguimiento clínico de cinco años, o hasta su fallecimiento. Resultados: El porcentaje de positividades para los niveles séricos preoperatorios del CEA (> 6 ng/ml) estuvo positiva y significativamente asociado con el estadio tumoral (A: 10,5 por ciento; B: 38,8 por ciento; C: 32,2 por ciento; y D: 72 por ciento; p < 0,0001). Además, los valores séricos elevados del antígeno estuvieron significativamente asociados, en el análisis univariante, con una supervivencia corta en el conjunto de los pacientes (p < 0,0001). Sin embargo, el análisis multivariante tan solo demostró valor pronóstico independiente del CEA en el subgrupo de pacientes con tumores en estadio C. Conclusiones: Los valores séricos preoperatorios del CEA tienen valor clínico para predecir la extensión de la enfermedad, así como para predecir el pronóstico de pacientes con cáncer colorrectal con estadio tumoral C. (AU)
Subject(s)
Middle Aged , Adult , Aged , Aged, 80 and over , Male , Female , Humans , Spain , Biomarkers, Tumor , Survival Analysis , Life Tables , Multivariate Analysis , Disease-Free Survival , Preoperative Care , Prospective Studies , Prognosis , Carcinoembryonic Antigen , Adenocarcinoma , Follow-Up Studies , Colorectal Neoplasms , Neoplasm Staging , Neoplasm ProteinsABSTRACT
OBJECTIVE: To analyze the prognostic value of the preoperative serum levels of the carcinoembryonic antigen (CEA) in primary colorectal carcinoma. MATERIAL AND METHODS: Preoperative serum levels of CEA were analyzed in 275 colorectal cancer patients, who were followed up for a minimum of 5 years, or until death. RESULTS: The percentage of positivities for the preoperative serum levels of CEA (> 6 ng/ml) was positively and significantly associated with the tumoral stage (A: 10,5%; B: 38,8%; C: 32,2%; y D: 72%; p < 0,0001). In addition, the elevated serum values of the antigen were significantly associated, in the univariate analysis, with short survival in the overall group of patients (p < 0,0001). However, the multivariate analysis only showed an independent prognosis value of the CEA in the subgroup of patients with stage C tumors. CONCLUSIONS: Preoperative serum levels of CEA may be useful to predict tumoral extension, and also for the prognosis regarding stage C colorectal cancer patients.
Subject(s)
Adenocarcinoma/blood , Biomarkers, Tumor/blood , Carcinoembryonic Antigen/blood , Colorectal Neoplasms/blood , Neoplasm Proteins/blood , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Disease-Free Survival , Female , Follow-Up Studies , Humans , Life Tables , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , Preoperative Care , Prognosis , Prospective Studies , Spain/epidemiology , Survival AnalysisABSTRACT
In this prospective study we have quantified by means of ELISA-methods the cytosolic content of estrogen (ER) and progesterone receptors (PgR) in tumoral tissue and paired normal mucosa from 163 patients with resectable colorectal cancer. Survival analysis was performed in a subgroup of 120 patients and the mean follow-up period was 24.9 months. The cutoff for ER and PgR levels was set at 1 fmol/mg protein. On the basis of this cutoff 20.9% of the cancers were ER positive and 25.8% were PgR positive; normal adjacent tissue presented ER in 18.4% and PgR in 24.5%. Our results did not show any significant correlation between ER and PgR levels in neoplastic tissues. Howewer, a correlation was found in normal mucosa samples (p=0.02). Statistical analysis showed that there was no correlation between tumor ER and PgR content and patient age or sex, tumor location, Dukes' stage, histological differentiation, DNA ploidy status and S-phase fraction. Furthermore, the results did not show any statistical differences in relapse-free and overall survival curves calculated for patients classified according to the hormone receptor content of their tumors. ER and PgR were detected at low levels in normal and neoplastic colorectal tissues without any significant relationship to either clinicopathological tumor characteristics or patient outcome. Their possible role in colorectal cancer remains to be elucidated.
Subject(s)
Colorectal Neoplasms/chemistry , Intestinal Mucosa/chemistry , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Adult , Aged , Colorectal Neoplasms/mortality , Female , Humans , Male , Middle Aged , PrognosisABSTRACT
The aim of this work is studying the behaviour of EGFR in benign breast pathologies and correlating it to its expression in CDI with hormonal dependency or independency using a radioligand technique. The EGFR expression was higher in FAD rather than in MFQ (mean +/- S.D.: 13.7 +/- 13.5; range: 1.0-55.3; median: 10.0 fmol/mg prot vs mean +/- S.D.: 4.0 +/- 3.5; range:1.0-11.4; median: 2.2 fmol/mg prot), with a result of a positive correlation in the first ones with RP (r = 0.4557) but not with RE. FAD present similar EGFR concentrations to those in CDI-hormonal independents (mean +/- S.D.: 10.7 +/- 12.6; range: 1.0-60.2; median: 6.75 fmol/mg prot), even though the way they are correlated with the content in RP leads us to the conclusion that they are both involved in the genesis and controled development of themselves. On the other hand, MFQ have got similar contents in EGFR to those of CDI hormono-dependents (mean +/- S.D.: 6.98 +/- 15.72; range: 1.0-118; median: 2.55 fmol/mg prot); this fact proves that the development of this pathology does not only depend on the growth factors but also on the hormonal environment which influences it.